Table:
begin	end	state
1	24	cytoplasmic
25	46	transmembrane
47	51	non-cytoplasmic
52	71	transmembrane
72	101	cytoplasmic
102	124	transmembrane
125	129	non-cytoplasmic
130	150	transmembrane
151	160	cytoplasmic
161	184	transmembrane
185	203	non-cytoplasmic
204	229	transmembrane
230	247	cytoplasmic
248	269	transmembrane
270	288	non-cytoplasmic
289	311	transmembrane
312	337	cytoplasmic
338	359	transmembrane
360	365	non-cytoplasmic
366	385	transmembrane
386	404	cytoplasmic
405	427	transmembrane
428	432	non-cytoplasmic
433	452	transmembrane
453	460	cytoplasmic

Input:
>WP_057509355.1 NCBI__GCF_001431535.1:WP_057509355.1
MPANPTPAAPASPPRLGHALKPRQLIMMGLGSAIGAGLFLGSGVGVQLAGPAVLLSYLVA
GALVIIVMNALGEMAANKPTSGAFSVYAADALGPTAGATVGWLWWVQLVIVIAAEAVGAA
GLLATVWTGLSVPMAALAFMLFFTAINLLGVKNFGEFEFWFAILKVAAILGFIAIGAALL
LGWLPDATSPGLSNFTGNGGFAPTGLAGVGAALLVVIFAFGGTEIVAVAAAETEDPERSI
ARAIRTVAWRILVFYIGSLSVIIAVVPWTSEALKSPFAAVLEAANIPGAGTAITLVAVIA
LLSALNANLYGASRMIFSLAQRREAPAVLGWADRRQVPVLAVLASVLFGFAATVMELVFP
DRVLPVLLNIVGSTCLLVWTLSLLSQLVLRRRADRAGVALPFRMAAFPWLTALALAILAL
IFALLLYGDQTRLQFLSMVVLTLFIAGCSAAARRLRSQAG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server